DUPIXENT® (dupilumab) Mechanism of Action
DUPIXENT binds to IL-4Rα, blocking IL-4 and IL-13 intracellular signaling, Two Type 2 cytokines that contribute to inflammation in Asthma.
MAT-QA-2200051/V1/Nov-2022
This website is intended exclusively for healthcare professionals residing and/or working in the KSA.
DUPIXENT binds to IL-4Rα, blocking IL-4 and IL-13 intracellular signaling, Two Type 2 cytokines that contribute to inflammation in Asthma.
MAT-QA-2200051/V1/Nov-2022
By clicking on this link, you will be leaving Campus Sanofi website and going to another, entirely independent website.
Please note: Sanofi provides these links as a service to its website visitors and users; however, Sanofi takes no responsibility for the information on any website but their own.